BIOSPECIFICS TECHNOL

BSTC
Delayed Quote. Delayed  - 11/27 01:00:00 pm
88.5USD +0.07%
Prev.88.4400
Open88.4600
High88.5000
Low88.4400
Volume29 559
Latest news
11/19
11/18
11/10
11/09
Chart BIOSPECIFICS TECHNOLOGIES CORP.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance88,988,9116
Spread/Res.-0,39%-0,39%-24%
Spread/Supp.30%30%42%
Support67,967,962,5
Financials
Sales 2020 28,5 M - -
Net income 2020 - - -
Net Debt 2020 - - -
P/E ratio 2020 -
Yield 2020 -
Capitalization 650 M 650 M -
Capi. / Sales 2020 22,8x
Capi. / Sales 2021 10,5x
Nbr of Employees -
Free-Float 73,7%
Company
BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2021-03-17 Earnings Release

Income Statement Evolution
Consensus
Mean consensus HOLD
Number of Analysts 1
Average target price 88,50 $
Last Close Price 88,44 $
Spread / Highest target 0,07%
Spread / Average Target 0,07%
Spread / Lowest Target 0,07%